The main purpose of the research study is to estimate the prevalence of tobacco product use and describe the tobacco use patterns in adults in Germany.
The aim of the survey is to describe the current and past patterns of use of tobacco products in the general adult population of Germany and in adult IQOS users registered in the IQOS user database of Philip Morris GmbH (Germany IQOS User Database), and explore their association with key independent variables. More specifically, the objectives are: 1. Estimate the prevalence of current tobacco use status in the study population. 2. Describe the past tobacco use status (cigarette, IQOS and other innovative products, including e-cigarettes) in the study population (i.e. never-use, initiation, product use transition, cessation, re-initiation, and relapse). 3. Explore the association between self-reported health status and use of tobacco products in the study population. 4. Explore the association between patterns of use (including misuse) with motivation to use, perceived quality attributes of IQOS (e.g. risk and self-reported changes since switching to the product, in a number of relevant domains where IQOS may have potential benefits), and consumer's satisfaction in the population of IQOS users in Germany registered in the Germany IQOS User Database.
Study Type
OBSERVATIONAL
Enrollment
6,284
Face-to-face survey to estimate the prevalence of current tobacco use status in the general population of Germany.
Online survey to describe patterns of use in adult IQOS users residing in Germany.
Philip Morris Products S.A.
Lausanne, Canton of Vaud, Switzerland
Prevalence of current tobacco use
Prevalence of current tobacco use status in the study population.
Time frame: Study duration (3 years).
Past tobacco use status
Past tobacco use status (cigarette, IQOS and other innovative products) in the study population.
Time frame: Study duration (3 years).
Self-reported health status
Association between self-reported health status and use of tobacco products in the study population.
Time frame: Study duration (3 years).
Perceived risk
Association between patterns of use with perceived risk.
Time frame: Study duration (3 years).
IQOS use experience
Describe the IQOS user experience, including motivation to use, mis-use, satisfaction, and self-reported changes since switching to the product (in a number of domains where IQOS may have potential benefits).
Time frame: Study duration (3 years).
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.